CBD Nutraceuticals Pazarı, Kronik Hastalık Yönetimi Talebinden Kaynaklanan 47.28'ye Kadar 2032 Milyar ABD Dolarına Ulaşacak. – Dünya Haberleri Raporu

Raporlar ve Veriler

The global Cannabidiol (CBD) nutraceuticals market size is expected to reach USD 47.28 billion in 2032, & register a revenue CAGR of 19% by 2032.

NEW YORK, NEW YORK, AMERİKA BİRLEŞİK DEVLETLERİ, 8 ​​Mayıs 2023 /EINPresswire.com/ — The demand for CBD Nutraceuticals Market is rising due to an increase in chronic illnesses such as diabetes, cancer, and arthritis. Research shows that CBD has anti-inflammatory effects, which can reduce pain and discomfort associated with these diseases. The legalization of cannabis in several countries has also led to revenue growth in the market for CBD nutraceuticals. This has created more awareness and acceptance of cannabis-based products for medicinal purposes.

Another factor driving revenue growth is the increasing wellness and self-care trend. Consumers are looking for natural cures to improve their overall well-being, and CBD nutraceuticals provide a natural and safe alternative to traditional medication. The accessibility of these products in different formats, such as oils, capsules, and gummies, has also contributed to the revenue growth of the market.

Moreover, major players in the industry are increasing their investment in R&D activities to develop new and improved CBD nutraceutical products. Collaboration between key players and research institutes is expected to drive innovation and lead to the creation of enhanced CBD…